ATC code L01

L01AA Nitrogen mustard analogues :L01AA01 Cyclophosphamide :L01AA02 Chlorambucil :L01AA03 Melphalan :L01AA05 Chlormethine :L01AA06 Ifosfamide :L01AA07 Trofosfamide :L01AA08 Prednimustine :L01AA09 Bendamustine :L01AA10 Melphalan flufenamide L01AB Alkyl sulfonates :L01AB01 Busulfan :L01AB02 Treosulfan :L01AB03 Mannosulfan L01AC Ethylene imines :L01AC01 Thiotepa :L01AC02 Triaziquone :L01AC03 Carboquone L01AD Nitrosoureas :L01AD01 Carmustine :L01AD02 Lomustine :L01AD03 Semustine :L01AD04 Streptozocin :L01AD05 Fotemustine :L01AD06 Nimustine :L01AD07 Ranimustine :L01AD08 Uramustine L01AG Epoxides :L01AG01 Etoglucid L01AX Other alkylating agents :L01AX01 Mitobronitol :L01AX02 Pipobroman :L01AX03 Temozolomide :L01AX04 Dacarbazine ==L01B Antimetabolites==

L01BA Folic acid analogues :L01BA01 Methotrexate :L01BA03 Raltitrexed :L01BA04 Pemetrexed :L01BA05 Pralatrexate L01BB Purine analogues :L01BB02 Mercaptopurine :L01BB03 Tioguanine :L01BB04 Cladribine :L01BB05 Fludarabine :L01BB06 Clofarabine :L01BB07 Nelarabine :QL01BB90 Rabacfosadine L01BC Pyrimidine analogues :L01BC01 Cytarabine :L01BC02 Fluorouracil :L01BC03 Tegafur :L01BC04 Carmofur :L01BC05 Gemcitabine :L01BC06 Capecitabine :L01BC07 Azacitidine :L01BC08 Decitabine :L01BC09 Floxuridine :L01BC52 Fluorouracil, combinations :L01BC53 Tegafur, combinations :L01BC58 Decitabine, combinations :L01BC59 Trifluridine, combinations ==L01C Plant alkaloids and other natural products==

L01CA Vinca alkaloids and analogues :L01CA01 Vinblastine :L01CA02 Vincristine :L01CA03 Vindesine :L01CA04 Vinorelbine :L01CA05 Vinflunine :L01CA06 Vintafolide L01CB Podophyllotoxin derivatives :L01CB01 Etoposide :L01CB02 Teniposide L01CC Colchicine derivatives :L01CC01 Demecolcine L01CD Taxanes :L01CD01 Paclitaxel :L01CD02 Docetaxel :L01CD03 Paclitaxel poliglumex :L01CD04 Cabazitaxel :L01CD51 Paclitaxel and encequidar L01CE Topoisomerase 1 (TOP1) inhibitors :L01CE01 Topotecan :L01CE02 Irinotecan :L01CE03 Etirinotecan pegol :L01CE04 Belotecan L01CX Other plant alkaloids and natural products :L01CX01 Trabectedin ==L01D Cytotoxic antibiotics and related substances==

L01DA Actinomycines :L01DA01 Dactinomycin L01DB Anthracyclines and related substances :L01DB01 Doxorubicin :L01DB02 Daunorubicin :L01DB03 Epirubicin :L01DB04 Aclarubicin :L01DB05 Zorubicin :L01DB06 Idarubicin :L01DB07 Mitoxantrone :L01DB08 Pirarubicin :L01DB09 Valrubicin :L01DB10 Amrubicin :L01DB11 Pixantrone L01DC Other cytotoxic antibiotics :L01DC01 Bleomycin :L01DC02 Plicamycin :L01DC03 Mitomycin :L01DC04 Ixabepilone :L01DC05 Utidelone ==L01E Protein kinase inhibitors==

L01EA BCR-ABL tyrosine kinase inhibitors :L01EA01 Imatinib :L01EA02 Dasatinib :L01EA03 Nilotinib :L01EA04 Bosutinib :L01EA05 Ponatinib :L01EA06 Asciminib L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors :L01EB01 Gefitinib :L01EB02 Erlotinib :L01EB03 Afatinib :L01EB04 Osimertinib :L01EB05 Rociletinib :L01EB06 Olmutinib :L01EB07 Dacomitinib :L01EB08 Icotinib :L01EB09 Lazertinib :L01EB10 Mobocertinib :L01EB11 Aumolertinib :L01EB12 Firmonertinib L01EC B-Raf serine-threonine kinase (BRAF) inhibitors :L01EC01 Vemurafenib :L01EC02 Dabrafenib :L01EC03 Encorafenib :L01EC04 Tovorafenib L01ED Anaplastic lymphoma kinase (ALK) inhibitors :L01ED01 Crizotinib :L01ED02 Ceritinib :L01ED03 Alectinib :L01ED04 Brigatinib :L01ED05 Lorlatinib L01EE Mitogen-activated protein kinase (MEK) inhibitors :L01EE01 Trametinib :L01EE02 Cobimetinib :L01EE03 Binimetinib :L01EE04 Selumetinib :L01EE05 Mirdametinib :L01EE06 Tunlametinib L01EF Cyclin-dependent kinase (CDK) inhibitors :L01EF01 Palbociclib :L01EF02 Ribociclib :L01EF03 Abemaciclib L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors :L01EG01 Temsirolimus :L01EG02 Everolimus :L01EG03 Ridaforolimus :L01EG04 Sirolimus L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors :L01EH01 Lapatinib :L01EH02 Neratinib :L01EH03 Tucatinib :L01EH04 Zongertinib :L01EH05 Mifanertinib :L01EH06 Sevabertinib L01EJ Janus-associated kinase (JAK) inhibitors :L01EJ01 Ruxolitinib :L01EJ02 Fedratinib :L01EJ03 Pacritinib :L01EJ04 Momelotinib L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors :L01EK01 Axitinib :L01EK02 Cediranib :L01EK03 Tivozanib :L01EK04 Fruquintinib :L01EK05 Rivoceranib L01EL Bruton's tyrosine kinase (BTK) inhibitors :L01EL01 Ibrutinib :L01EL02 Acalabrutinib :L01EL03 Zanubrutinib :L01EL04 Orelabrutinib :L01EL05 Pirtobrutinib :L01EL06 Tirabrutinib L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors :L01EM01 Idelalisib :L01EM02 Copanlisib :L01EM03 Alpelisib :L01EM04 Duvelisib :L01EM05 Parsaclisib :L01EM06 Inavolisib L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors :L01EN01 Erdafitinib :L01EN02 Pemigatinib :L01EN03 Infigratinib :L01EN04 Futibatinib L01EP Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors :L01EP01 Capmatinib :L01EP02 Tepotinib :L01EP03 Savolitinib L01EX Other protein kinase inhibitors :L01EX01 Sunitinib :L01EX02 Sorafenib :L01EX03 Pazopanib :L01EX04 Vandetanib :L01EX05 Regorafenib :L01EX06 Masitinib :L01EX07 Cabozantinib :L01EX08 Lenvatinib :L01EX09 Nintedanib :L01EX10 Midostaurin :L01EX11 Quizartinib :L01EX12 Larotrectinib :L01EX13 Gilteritinib :L01EX14 Entrectinib :L01EX15 Pexidartinib :L01EX18 Avapritinib :L01EX19 Ripretinib :L01EX22 Selpercatinib :L01EX23 Pralsetinib :L01EX24 Surufatinib :L01EX25 Umbralisib :L01EX26 Sitravatinib :L01EX27 Capivasertib :L01EX28 Repotrectinib :L01EX29 Vimseltinib :QL01EX90 Toceranib ==L01F Monoclonal antibodies and antibody drug conjugates==

L01FA CD20 (clusters of differentiation 20) inhibitors :L01FA01 Rituximab :L01FA02 Ofatumumab :L01FA03 Obinutuzumab L01FB CD22 (clusters of differentiation 22) inhibitors :L01FB01 Inotuzumab ozogamicin :L01FB02 Moxetumomab pasudotox L01FC CD38 (clusters of differentiation 38) inhibitors :L01FC01 Daratumumab :L01FC02 Isatuximab L01FD HER2 (human epidermal growth factor receptor 2) inhibitors :L01FD01 Trastuzumab :L01FD02 Pertuzumab :L01FD03 Trastuzumab emtansine :L01FD04 Trastuzumab deruxtecan :L01FD05 Trastuzumab duocarmazine :L01FD06 Margetuximab :L01FD07 Zanidatamab L01FE EGFR (epidermal growth factor receptor) inhibitors :L01FE01 Cetuximab :L01FE02 Panitumumab :L01FE03 Necitumumab L01FF PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors :L01FF01 Nivolumab :L01FF02 Pembrolizumab :L01FF03 Durvalumab :L01FF04 Avelumab :L01FF05 Atezolizumab :L01FF06 Cemiplimab :L01FF07 Dostarlimab :L01FF08 Prolgolimab :L01FF09 Tislelizumab :L01FF10 Retifanlimab :L01FF11 Sugemalimab :L01FF12 Serplulimab :L01FF13 Toripalimab :L01FF14 Camrelizumab :L01FF15 Envafolimab :L01FF16 Sasanlimab L01FG VEGF/VEGFR (vascular endothelial growth factor) inhibitors :L01FG01 Bevacizumab :L01FG02 Ramucirumab L01FX Other monoclonal antibodies and antibody drug conjugates :L01FX01 Edrecolomab :L01FX02 Gemtuzumab ozogamicin :L01FX03 Catumaxomab :L01FX04 Ipilimumab :L01FX05 Brentuximab vedotin :L01FX06 Dinutuximab beta :L01FX07 Blinatumomab :L01FX08 Elotuzumab :L01FX09 Mogamulizumab :L01FX10 Olaratumab :L01FX11 Bermekimab :L01FX12 Tafasitamab :L01FX13 Enfortumab vedotin :L01FX14 Polatuzumab vedotin :L01FX15 Belantamab mafodotin :L01FX16 Oportuzumab monatox :L01FX17 Sacituzumab govitecan :L01FX18 Amivantamab :L01FX19 Sabatolimab :L01FX20 Tremelimumab :L01FX21 Naxitamab :L01FX22 Loncastuximab tesirine :L01FX23 Tisotumab vedotin :L01FX24 Teclistamab :L01FX25 Mosunetuzumab :L01FX26 Mirvetuximab soravtansine :L01FX27 Epcoritamab :L01FX28 Glofitamab :L01FX29 Talquetamab :L01FX31 Zolbetuximab :L01FX32 Elranatamab :L01FX33 Tarlatamab :L01FX34 Odronextamab :L01FX35 Datopotamab deruxtecan :L01FX36 Patritumab deruxtecan :L01FX37 Linvoseltamab :L01FX38 Ifinatamab deruxtecan :L01FX39 Bemarituzumab L01FY Combinations of monoclonal antibodies and antibody drug conjugates :L01FY01 Pertuzumab and trastuzumab :L01FY02 Nivolumab and relatlimab :L01FY03 Prolgolimab and nurulimab ==L01X Other antineoplastic agents==

L01XA Platinum compounds :L01XA01 Cisplatin :L01XA02 Carboplatin :L01XA03 Oxaliplatin :L01XA04 Satraplatin :L01XA05 Polyplatillen L01XB Methylhydrazines :L01XB01 Procarbazine L01XD Sensitizers used in photodynamic/radiation therapy :L01XD01 Porfimer sodium :L01XD03 Methyl aminolevulinate :L01XD04 Aminolevulinic acid :L01XD05 Temoporfin :L01XD06 Efaproxiral :L01XD07 Padeliporfin L01XF Retinoids for cancer treatment :L01XF01 Tretinoin :L01XF02 Alitretinoin :L01XF03 Bexarotene L01XG Proteasome inhibitors :L01XG01 Bortezomib :L01XG02 Carfilzomib :L01XG03 Ixazomib L01XH Histone deacetylase (HDAC) inhibitors :L01XH01 Vorinostat :L01XH02 Romidepsin :L01XH03 Panobinostat :L01XH04 Belinostat :L01XH05 Entinostat :L01XH06 Tucidinostat :L01XH07 Resminostat L01XJ Hedgehog pathway inhibitors :L01XJ01 Vismodegib :L01XJ02 Sonidegib :L01XJ03 Glasdegib L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors :L01XK01 Olaparib :L01XK02 Niraparib :L01XK03 Rucaparib :L01XK04 Talazoparib :L01XK05 Veliparib :L01XK06 Pamiparib :L01XK07 Senaparib :L01XK52 Niraparib and abiraterone L01XL Antineoplastic cell and gene therapy :L01XL01 Sitimagene ceradenovec :L01XL02 Talimogene laherparepvec :L01XL03 Axicabtagene ciloleucel :L01XL04 Tisagenlecleucel :L01XL05 Ciltacabtagene autoleucel :L01XL06 Brexucabtagene autoleucel :L01XL07 Idecabtagene vicleucel :L01XL08 Lisocabtagene maraleucel :L01XL09 Tabelecleucel :L01XL10 Nadofaragene firadenovec :L01XL11 Lifileucel :L01XL12 Obecabtagene autoleucel L01XM Isocitrate dehydrogenase (IDH) inhibitors :L01XM01 Enasidenib :L01XM02 Ivosidenib :L01XM03 Olutasidenib :L01XM04 Vorasidenib L01XU Other antineoplastic agents (cont.) :Empty group L01XX Other antineoplastic agents :L01XX01 Amsacrine :L01XX02 Asparaginase :L01XX03 Altretamine :L01XX05 Hydroxycarbamide :L01XX07 Lonidamine :L01XX08 Pentostatin :L01XX10 Masoprocol :L01XX11 Estramustine :L01XX16 Mitoguazone :L01XX18 Tiazofurine :L01XX23 Mitotane :L01XX24 Pegaspargase :L01XX27 Arsenic trioxide :L01XX29 Denileukin diftitox :L01XX33 Celecoxib :L01XX35 Anagrelide :L01XX36 Oblimersen :L01XX40 Omacetaxine mepesuccinate :L01XX41 Eribulin :L01XX44 Aflibercept :L01XX46 Olaparib :L01XX52 Venetoclax :L01XX53 Vosaroxin :L01XX57 Plitidepsin :L01XX58 Epacadostat :L01XX66 Selinexor :L01XX67 Tagraxofusp :L01XX69 Lurbinectedin :L01XX72 Tazemetostat :L01XX73 Sotorasib :L01XX74 Belzutifan :L01XX75 Tebentafusp :L01XX77 Adagrasib :L01XX78 Navitoclax :L01XX79 Eflornithine :L01XX80 Imetelstat :L01XX81 Nirogacestat :L01XX82 Darinaparsin :L01XX83 Para-toluenesulfonamide :L01XX84 Pelabresib :L01XX85 Idroxioleic acid :L01XX86 Calaspargase pegol :L01XX87 Revumenib :QL01XX91 Tigilanol tiglate :QL01XX92 Verdinexor L01XY Combinations of antineoplastic agents :L01XY01 Cytarabine and daunorubicin :L01XY04 Bifikafusp alfa and onfekafusp alfa ==References==